Learn More
Medchemexpress LLC Mc-val-cit-pab-doxorubicin | 159857-70-2 | MFCD32693347 | 99.7% | 1142.17 | C56H67N7O19 | 25 MG

Supplier: Medchemexpress LLC HYW19092725MG
MC-Val-Cit-Doxorubicin is a drug-linker conjugate used as an ADC payload and precursor in research. It couples doxorubicin to a Val-Cit-PAB cleavable linker and is designed for conjugation to thiol-containing molecules via a maleimide, enabling enzymatic release of the cytotoxic payload in target cells.
- Val-Cit cleavable peptide linker enables enzymatic payload release.
- Maleimide functionality enables conjugation to thiol-containing biomolecules.
- Includes doxorubicin as the cytotoxic payload for ADC research.
- High purity 99.7% suitable for analytical and synthetic workflows.
- Available in multiple small-scale sizes for research needs.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.